Lantheus Holdings (LNTH) Net Cash Flow (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Net Cash Flow came in at $139.5 million in Q1 2026, up 444.33% year-on-year from $25.6 million in Q1 2025, and up 730.66% on a QoQ basis from -$22.1 million in Q4 2025.
Lantheus Holdings (LNTH) Net Cash Flow (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Net Cash Flow data on file, last reported at $139.5 million in Q1 2026.
- On a quarterly basis, Net Cash Flow rose 444.33% year-over-year to $139.5 million in Q1 2026; TTM through Mar 2026 was -$439.7 million, a 298.12% decrease from a year earlier, with the FY2025 full-year figure at -$553.6 million, down 376.53% from the prior year.
- Net Cash Flow for Q1 2026 stood at $139.5 million, up from -$22.1 million in the prior quarter.
- Over the last five years, Net Cash Flow for LNTH reached as high as $200.1 million in Q3 2023 and fell as low as -$313.3 million in Q3 2025.
- Historically, Net Cash Flow has averaged $23.6 million across 5 years, with a median of $47.5 million in 2024.
- Across the five-year window, Net Cash Flow surged 43981.96% in 2022 and slumped 713.54% in 2025, its largest moves.
- Year by year, Net Cash Flow stood at $158.5 million in 2022, then sank by 37.04% to $99.8 million in 2023, then sank by 52.42% to $47.5 million in 2024, then sank by 146.59% to -$22.1 million in 2025, then jumped by 730.66% to $139.5 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were $139.5 million in Q1 2026, -$22.1 million in Q4 2025, and -$313.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 139.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.49 Mn |
| Mar 31, 2026 | 139.49 Mn |
| Dec 31, 2025 | -22.12 Mn |
| Dec 31, 2025 | -22.12 Mn |
| Sep 30, 2025 | -313.34 Mn |
| Sep 30, 2025 | -313.34 Mn |
| Jun 30, 2025 | -243.78 Mn |
| Jun 30, 2025 | -243.78 Mn |
| Mar 31, 2025 | 25.63 Mn |
| Mar 31, 2025 | 25.63 Mn |
| Dec 31, 2024 | 47.47 Mn |
| Dec 31, 2024 | 47.47 Mn |
| Sep 30, 2024 | 109.13 Mn |
| Sep 30, 2024 | 109.13 Mn |
| Jun 30, 2024 | 39.73 Mn |
| Jun 30, 2024 | 39.73 Mn |
| Mar 31, 2024 | 3.86 Mn |
| Mar 31, 2024 | 3.86 Mn |
| Dec 31, 2023 | 99.77 Mn |
| Dec 31, 2023 | 99.77 Mn |